144 related articles for article (PubMed ID: 38110824)
21. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
Akkız H
Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
[TBL] [Abstract][Full Text] [Related]
22. Receptor binding domain proteins of SARS-CoV-2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern.
Khorattanakulchai N; Manopwisedjaroen S; Rattanapisit K; Panapitakkul C; Kemthong T; Suttisan N; Srisutthisamphan K; Malaivijitnond S; Thitithanyanont A; Jongkaewwattana A; Shanmugaraj B; Phoolcharoen W
J Med Virol; 2022 Sep; 94(9):4265-4276. PubMed ID: 35615895
[TBL] [Abstract][Full Text] [Related]
23. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
[TBL] [Abstract][Full Text] [Related]
24. Fluorescent nanodiamond-based spin-enhanced lateral flow immunoassay for detection of SARS-CoV-2 nucleocapsid protein and spike protein from different variants.
Wei-Wen Hsiao W; Sharma N; Le TN; Cheng YY; Lee CC; Vo DT; Hui YY; Chang HC; Chiang WH
Anal Chim Acta; 2022 Oct; 1230():340389. PubMed ID: 36192062
[TBL] [Abstract][Full Text] [Related]
25. Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by Beta and Omicron variants.
Chang MR; Ke H; Coherd CD; Wang Y; Mashima K; Kastrunes GM; Huang CY; Marasco WA
EBioMedicine; 2022 Jun; 80():104025. PubMed ID: 35533497
[TBL] [Abstract][Full Text] [Related]
26. CRISPR-Cas13a-powered electrochemical biosensor for the detection of the L452R mutation in clinical samples of SARS-CoV-2 variants.
Chen Z; Wu C; Yuan Y; Xie Z; Li T; Huang H; Li S; Deng J; Lin H; Shi Z; Li C; Hao Y; Tang Y; You Y; Al-Hartomy OA; Wageh S; Al-Sehemi AG; Lu R; Zhang L; Lin X; He Y; Zhao G; Li D; Zhang H
J Nanobiotechnology; 2023 Apr; 21(1):141. PubMed ID: 37120637
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection.
Richardson JR; Götz R; Mayr V; Lohse MJ; Holthoff HP; Ungerer M
PLoS One; 2022; 17(4):e0266701. PubMed ID: 35468147
[TBL] [Abstract][Full Text] [Related]
28. Sensitive Lateral Flow Immunoassay Based on Specific Peptide and Superior Oxidase Mimics with a Universal Dual-Mode Significant Signal Amplification.
Dong T; Zhang X; Yuan J; Lin Z; Yin P; Yu H; Wang M; Liu A
Anal Chem; 2023 Aug; 95(33):12532-12540. PubMed ID: 37553756
[TBL] [Abstract][Full Text] [Related]
29. Colorimetric and electrochemical detection of SARS-CoV-2 spike antigen with a gold nanoparticle-based biosensor.
Karakuş E; Erdemir E; Demirbilek N; Liv L
Anal Chim Acta; 2021 Oct; 1182():338939. PubMed ID: 34602210
[TBL] [Abstract][Full Text] [Related]
30. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination.
Chen LL; Lu L; Choi CY; Cai JP; Tsoi HW; Chu AW; Ip JD; Chan WM; Zhang RR; Zhang X; Tam AR; Lau DP; To WK; Que TL; Yip CC; Chan KH; Cheng VC; Yuen KY; Hung IF; To KK
Clin Infect Dis; 2022 May; 74(9):1623-1630. PubMed ID: 34309648
[TBL] [Abstract][Full Text] [Related]
31. Rapid and Quantitative Detection of Human Antibodies against the 2019 Novel Coronavirus SARS CoV2 and Its Variants as a Result of Vaccination and Infection.
Taubner B; Peredo-Wende R; Ramani A; Singh G; Strle K; Cady NC
Microbiol Spectr; 2021 Oct; 9(2):e0089021. PubMed ID: 34585942
[TBL] [Abstract][Full Text] [Related]
32. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
[TBL] [Abstract][Full Text] [Related]
33. Single-step, wash-free digital immunoassay for rapid quantitative analysis of serological antibody against SARS-CoV-2 by photonic resonator absorption microscopy.
Zhao B; Che C; Wang W; Li N; Cunningham BT
Talanta; 2021 Apr; 225():122004. PubMed ID: 33592744
[TBL] [Abstract][Full Text] [Related]
34. Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages.
Osterman A; Krenn F; Iglhaut M; Badell I; Lehner A; Späth PM; Stern M; Both H; Bender S; Muenchhoff M; Graf A; Krebs S; Blum H; Grimmer T; Durner J; Czibere L; Dächert C; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT
Med Microbiol Immunol; 2023 Oct; 212(5):307-322. PubMed ID: 37561226
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History.
Drews SJ; Hu Q; Samson R; Abe KT; Rathod B; Colwill K; Gingras AC; Yi QL; O'Brien SF
Microbiol Spectr; 2022 Feb; 10(1):e0226221. PubMed ID: 35171006
[TBL] [Abstract][Full Text] [Related]
36. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
Front Immunol; 2021; 12():691715. PubMed ID: 34149735
[TBL] [Abstract][Full Text] [Related]
37. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.
Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H
Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323
[TBL] [Abstract][Full Text] [Related]
38. Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen.
Eissa S; Alhadrami HA; Al-Mozaini M; Hassan AM; Zourob M
Mikrochim Acta; 2021 May; 188(6):199. PubMed ID: 34041585
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
40. Differential avidity determination of IgG directed towards the receptor-binding domain (RBD) of SARS-CoV-2 wild-type and its variants in one assay: Rational tool for the assessment of protective immunity.
Bauer G; Struck F; Staschik E; Maile J; Wochinz-Richter K; Motz M; Soutschek E
J Med Virol; 2022 Nov; 94(11):5294-5303. PubMed ID: 35851961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
